Literature DB >> 6490094

Antisera specificities to 1-ethyl-3-(3-dimethylaminopropyl) carbodiimide adducts of proteins.

L E Davis, S A Roth, B Anderson.   

Abstract

Animals were immunized with either 1-ethyl-3-(3-dimethylaminopropyl)carbodiimide (EDCI)-coupled peptide hapten-protein carrier conjugates or with N-acylurea EDCI derived protein carrier. Sera from all animals demonstrated antibody to N-acylurea EDCI when tested by double immunodiffusion using N-acylurea EDCI coupled to a heterologous carrier. Two rabbit antisera, one produced to EDCI-coupled peptide-24-thyroglobulin and another produced to N-acylurea EDCI derived thyroglobulin were further characterized using an enzyme-linked immunosorbent assay (ELISA). Competitive binding assays using either EDCI-coupled peptide-protein conjugates or N-acylurea EDCI derived proteins demonstrated the presence of N-acylurea EDCI reactive antibodies. Such antibodies were also shown to react with the EDCI isourea employed as inhibitor. The specificity of the anti-EDCI antibodies to portions of the EDCI molecule was demonstrated using structural analogues of EDCI. Both 3-dimethylaminopropylamine and 2-dimethylaminoethanol effectively inhibited anti-N-acylurea EDCI reactivity. These results show that when EDCI is used as a coupling agent, antibody is produced to N-acylurea EDCI-carrier, the antibody being primarily directed to the 3-dimethylaminopropyl end of the EDCI molecule.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6490094      PMCID: PMC1454907     

Source DB:  PubMed          Journal:  Immunology        ISSN: 0019-2805            Impact factor:   7.397


  10 in total

1.  Detection of the stable addition of carbodiimide to proteins.

Authors:  R Timkovich
Journal:  Anal Biochem       Date:  1977-05-01       Impact factor: 3.365

2.  [A new method for synthesis of peptides: activation of the carboxyl group with dicyclohexylcarbodiimide using 1-hydroxybenzotriazoles as additives].

Authors:  W König; R Geiger
Journal:  Chem Ber       Date:  1970

3.  A sensitive method for staining proteins transferred to nitrocellulose sheets.

Authors:  Z Wojtkowiak; R C Briggs; L S Hnilica
Journal:  Anal Biochem       Date:  1983-03       Impact factor: 3.365

4.  The use of carbodiimides in the preparation of immunizing conjugates.

Authors:  S Bauminger; M Wilchek
Journal:  Methods Enzymol       Date:  1980       Impact factor: 1.600

5.  Polymer enhancement of automated immunological nephelometric analysis, as illustrated by determination of urinary albumin.

Authors:  J Lizana; K Hellsing
Journal:  Clin Chem       Date:  1974-04       Impact factor: 8.327

6.  Isolation of in situ crosslinked ligand-receptor complexes using an anticrosslinker specific antibody.

Authors:  K Ballmer-Hofer; V Schlup; P Burn; M M Burger
Journal:  Anal Biochem       Date:  1982-11-01       Impact factor: 3.365

7.  Methods and applications of hapten-sandwich labeling.

Authors:  L Wofsy
Journal:  Methods Enzymol       Date:  1983       Impact factor: 1.600

8.  ANTIBODIES TO BRADYKININ AND ANGIOTENSIN: A USE OF CARBODIIMIDES IN IMMUNOLOGY.

Authors:  T L GOODFRIEND; L LEVINE; G D FASMAN
Journal:  Science       Date:  1964-06-12       Impact factor: 47.728

9.  BrucELISA: an enzyme-antibody immunoassay for detection of Brucella abortus antibodies in milk: correlation with the Brucella ring test and with shedding of viable organisms.

Authors:  D K Boraker; W R Stinebring; J R Kunkel
Journal:  J Clin Microbiol       Date:  1981-10       Impact factor: 5.948

10.  Preparation and specificities of antisera to the amino-terminal sequence of the carcinoembryonic antigen.

Authors:  D Paul; G Flouret; J T Tomita; K Ranney; J Schenck; B Anderson
Journal:  Cancer Res       Date:  1981-06       Impact factor: 12.701

  10 in total
  1 in total

1.  Improved method for synthesis of cysteine modified hyaluronic acid for in situ hydrogel formation.

Authors:  Xin Zhang; Pengcheng Sun; Lingzi Huangshan; Bi-Huang Hu; Phillip B Messersmith
Journal:  Chem Commun (Camb)       Date:  2015-06-14       Impact factor: 6.222

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.